Skip to main content

Inhibikase Therapeutics, Inc.

For the period ended Jan 3, 2025. Filed Nov 18, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jan 3, 2025 · Filed Nov 18, 2024

IKT$1.50+4.2%Stored close · as of Nov 6, 2026
Opening this filing…